SPEAR

Research on doxyPEP to prevent sexually transmitted infections, antimicrobial resistance & microbiome. Led by Dr Manik Kohli @UCL_CRISH. Funders NIHR/BHIVA/BIA.

[Michael Traeger @michael_traeger]

Out today - We looked at doxyPEP uptake among >11,000 PrEP users at Kaiser Permanente Northern California.. 1 in 5 started #doxyPEP within a year of availability, and STI incidence declined following uptake. Prescribing DoxyPEP outside of clinical trials reduces STIs.

[SPEAR @SPEARstudy]

We are open for recruitment! The
@SPEARstudy is investigating antibiotic resistance and microbiome changes in people using and not using doxyPEP to prevent STIs. Visit https://t.co/qOGVdmRbtn

[SPEAR @SPEARstudy]

We are open for recruitment! The @SPEARstudy is investigating antibiotic resistance and microbiome changes in people using and not using doxyPEP to prevent STIs. More details below https://t.co/qOGVdmRJiV